@ 2013 SEBIO Investor & Partnering Forum Highlights | SEBIO

2013 SEBIO Investor & Partnering Forum Highlights

Posted by on Oct 25, 2013

Register today to be part of the Southeast region’s premier life sciences and medical technology conference, expected to draw more than 300 attendees, including investors from over 30 regional and national venture funds, corporate executives, entrepreneurs, professional service providers and representatives from the region’s top research universities and institutes.

Hear from featured keynote speakers, Aneesh Chopra of The Advisory Board Company and Eli Lilly and Company’s Darren Carroll. See the region’s best early and later stage life science and medical technology companies.

Panel Session Spotlight:
Medical Device Breakfast and Panel: Solving for Capital in the MedTech Industry – Current Challenges and Opportunities
Wayne Roe, Incube Ventures (moderator)
Tom Callaway, HealthQuest Capital
Elizabeth Good Mazhari, Johns Hopkins University School of Medicine
Seth Rudnick, Canaan Partners

Biotech/Pharma Breakfast and Panel: Private-Public Partnerships in Translational Science
John McKew, National Institutes of Health (moderator)
Bill Moore, Viamet Pharmaceuticals
Elizabeth Ottinger, National Institutes of Health

Interested in Learning About Option Transactions?
Hear from Vascular Pharmaceuticals’ CEO Rich Shea, his lead investor Intersouth Partners, and his corporate partner Johnson & Johnson Development Corporation, as they discuss Option Transactions and Venture Capital/Pharma Funding Collaborations.

To view the entire conference program, visit our online agenda.

Network with active Life Sciences Funds:
Canaan Partners
HIG BioVentures
Harbert Venture Partners
Hatteras Venture Partners
HealthQuest Capital
InCube Ventures
Intersouth Partners
J&J Development Corp.
Lilly Ventures
Longitude Capital
Lumira Capital
MedImmune Ventures
NEA
Pappas Ventures
Rock Spring Ventures
Sofinnova Ventures
Syngenta Ventures
and many more!

Other Highlights
For investors and C-level executives, SEBIO will hold its 4th Annual Corporate Partnering Day, where senior executives from AstraZeneca and MedImmune will discuss their partnering approach and strategic areas of interest.

All registered attendees have access to the SEBIO/Connect online partnering system to facilitate one-on-one onsite meetings with other attendees, and there will be plenty of opportunities for informal networking throughout the conference.

For more details about the Investor Forum, sponsorship, accommodations and registration, visit the SEBIO 2013 website.

Questions? Contact our Executive Director, Suzanne Cantando. See you in Richmond!

Leave a Reply